In return, Royalty will receive a 9.25% royalty on worldwide sales of tividenofusp alfa from Denali until it reaches three times the amount Royalty has handed to Denali—or, alternatively, 2.5 times ...

The 2026 GMC Yukon is a large SUV that's as luxurious as it is comfortable. This mainstream model can compete against more ...

Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.

The 2026 Yukon 4WD Denali Ultimate is leveraging GMC’s strong foundation and sculpted it into something that doesn’t just carry families and pulls trailers. It carries status and intent. At first ...

Planning a Denali climb? Proper human waste disposal is critical for environmental protection and health. Learn how Clean ...

Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa ...

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...

I drive cars and review them here, sharing honest impressions, real-world performance, and practical insights for everyday ...

Alaska’s senior senator is again trying to move mountains to get the White House to restore Denali as the official name of ...

Investing.com -- Denali Therapeutics Inc. (NASDAQ:DNLI) stock dropped 7.2% in after-hours trading on Tuesday after the company announced plans to offer $200 million of common stock and pre-funded ...

Denali Therapeutics shares were lower in premarket trading Wednesday after it priced its share offering below current trading levels. Shares were down 9.7% ahead of the morning bell at $17.75. The ...

Recent Performance and Context Denali Therapeutics (DNLI) has quietly put together a strong month, with the stock climbing roughly 33% even as its one year return remains negative. This combination ...